COMP <GO>
ETS vs TMO // ENTERPRISE SCALE & MARKET CAP
Elite Express Holding Inc. (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ETS 1
— TMO 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $1.73 (+7.45%) • MKT CAP: $84.3M
market-cap
$84.3M
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ETS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ETS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 0.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.60% | 9.30% | -25.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.45% | 2.40% | -5.85 | TMO | /fcf-yield <GO> |
| Operating Margin | -60.00% | 17.40% | -77.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 15.10% | -75.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 21.60% | 3.90% | +17.70 | ETS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 8/9 | -6.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 62.9 | -14.54 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $84.3M | $262.22B | -$262.13B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ETS REV | TMO REV | ETS GROSS % | TMO GROSS % | ETS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.7M | $44.56B | 0.7% | — | -$2.9M | $6.29B |
| FY 2024 | $2.2M | $42.88B | 3.1% | — | $203.8K | $7.27B |
| FY 2023 | — | $42.86B | — | — | — | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ETS // BETA —
TMO // BETA 0.94